查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618510

白血球去除术市场：按类型、应用和最终用户划分 - 全球预测 2025-2030

Leukapheresis Market by Type (Leukapheresis Devices, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年白血球去除疗法市场价值为5,621万美元，预计到2024年将达到6,162万美元，复合年增长率为9.71%，预计到2030年将达到10,758万美元。

白血球分离术是一种从血液中分离白血球的特殊程序，用于治疗和治疗，特别是收集细胞以治疗白血病和淋巴瘤等疾病，或在 CAR T 细胞疗法等先进治疗中发挥重要作用。 。这种需求主要源于对准确的血液成分分离的需求，既可以用于即时治疗性介入，也可以用于在新兴的细胞研究领域中培养细胞。白血球去除术应用涵盖临床、商业和研究领域，最终用途为医院、研究机构和生物技术公司。市场成长是由血液相关疾病的增加、细胞治疗方法的进步以及对个人化医疗的日益关注所推动的。新的商机在于改进单采技术并利用人工智慧整合进行流程优化。专注于细胞治疗的生物技术新兴企业的激增进一步凸显了潜在的市场扩张。然而，挑战包括程序成本高、监管复杂性以及发展中地区的意识低。创新机会存在于白血球分离设备的自动化和提高效率、改善捐赠者安全通讯协定以及降低营运成本。该市场是动态的，其特点是技术的快速进步以及医疗保健提供者和生物技术公司之间的合作。儘管面临挑战，但扩大单采技术范围和效率的广泛研发投资和跨部门伙伴关係可以推动市场成长。公司可以透过资料分析和机器学习创新来利用不断发展的精准医疗领域，以完善患者选择策略并个人化治疗结果。未来的研究可以专注于具有成本效益和可扩展的技术以及更广泛的教育倡议，以提高渗透率较低的市场的意识。随着市场应对这些复杂性，新兴市场的策略定位、技术改进以及遵守不断变化的监管标准对于持续成长至关重要。

主要市场统计
基准年[2023] 5621万美元
预计年份 [2024] 6162万美元
预测年份 [2030] 10758万美元
复合年增长率（%） 9.71%

市场动态：揭示快速发展的白血球分离术市场的关键市场洞察

供需的动态交互作用正在改变白血球分离术市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 扩大癌症治疗的应用
    • 临床研究对白血球分离术的需求
    • 加大捐血力度
  • 市场限制因素
    • 治疗费用高
  • 市场机会
    • 研发活动的重点与投资
    • CAR 或过继性细胞疗法白血球去除术
  • 市场问题
    • 与白血球分离术相关的潜在问题，包括不适、发红和瘀伤

波特的五力：驾驭白血球分离术市场的策略工具

波特的五力架构是了解白血球分离术市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解白血球分离术市场的外部影响

外部宏观环境因素在塑造白血球分离市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解白血球分离术市场的竞争格局

对白血球去除疗法市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：白血球去除术市场供应商的绩效评估

FPNV 定位矩阵是评估白血球分离市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製白血球分离术市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，白血球分离术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大癌症治疗的应用
      • 临床研究对白血球分离术的需求
      • 扩大捐血活动
    • 抑制因素
      • 手续成本高
    • 机会
      • 研发活动的重点与投资
      • CAR 或过继性细胞疗法白血球去除术
    • 任务
      • 与白血球分离术相关的潜在问题，例如不适、发红和瘀伤
  • 市场区隔分析
    • 类型：增加使用白血球分离装置有效分离白血球
    • 用途：增加白血球去除术在治疗上的应用，以改善患者的治疗效果
    • 最终用户：血液成分供应商和血液中心对白血球分离设备的使用激增
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章白血球去除术市场：依类型

  • 介绍
  • 装置
    • 离心分离机
    • 膜分离设备
  • 消耗品

第七章白血球去除术市场：依应用分类

  • 介绍
  • 研究用途
  • 治疗用途

第八章白血球去除术市场：依最终用户分类

  • 介绍
  • 学术研究所
  • 血液成分供应商和血液中心
  • 合约研究组织
  • 医院及输血中心
  • 製药和生物技术公司

第九章北美和南美白血球去除治疗市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太白血球分离市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的白血球去除术市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • SCTbio 与 Cyto-Care 合作改善细胞治疗的冷冻保存
    • Akadeum 利用正选推出 T 细胞活化和扩增，扩大了 Leukopak 细胞分离产品线
    • Fresenius Kabi 推出 Amicus体外光化学疗法通讯协定的单针选项
  • 战略分析和建议

公司名单

  • Allcells, LLC
  • Asahi Kasei Corporation
  • Beijing Zksk Technology Co. Ltd.
  • Bioivt
  • Caltag Medsystems Limited
  • Charles River Laboratories International, Inc.
  • Discovery Life Sciences
  • Fresenius Se & Co. Kgaa
  • Guangzhou Daji Medical Science and Technology Co. Ltd.
  • Haemonetics Corporation
  • Intelligent Tissue Group
  • Lonza Group Ag
  • Macopharma Sa
  • Medica Spa.
  • Miltenyi BIoTec
  • Precision for Medicine, Inc.
  • Puriblood Medical Co. Ltd.
  • Stemexpress, LLC
  • Terumo BCT
  • Zenbio, Inc.
Product Code: MRR-FD3F12D52871

The Leukapheresis Market was valued at USD 56.21 million in 2023, expected to reach USD 61.62 million in 2024, and is projected to grow at a CAGR of 9.71%, to USD 107.58 million by 2030.

Leukapheresis, a specialized procedure to separate leukocytes (white blood cells) from the blood, plays a critical role in therapeutic and research settings, particularly in treating conditions like leukemia and lymphoma and for harvesting cells for advanced therapies like CAR T-cell therapies. Its necessity arises primarily from the need for precise blood component separation for both immediate therapeutic interventions and the cultivation of cells in burgeoning cell-based research. The application of leukapheresis spans clinical, commercial, and research domains, with end-use in hospitals, research institutes, and biotechnology companies. Market growth is fueled by rising incidences of blood-related disorders, advancements in cell-based therapies, and an increasing focus on personalized medicine. Emerging opportunities lie in leveraging improvements in apheresis technologies and the integration of AI for process optimization. The proliferation of biotech startups focusing on cell therapy further underscores potential market expansion. However, challenges include high procedure costs, regulatory complexities, and limited awareness in developing regions. Innovation opportunities exist in enhancing automation and efficiency of leukapheresis devices, improving donor safety protocols, and reducing operational costs. The market is dynamic, characterized by rapid technological advancements and collaboration between healthcare providers and biotechnology firms. Despite the challenges, extensive R&D investment in expanding the scope and efficiency of apheresis technologies and cross-sector partnerships can foster market growth. Companies may capitalize on the developing precision medicine sector by innovating in data analytics and machine learning to refine patient-selection strategies and personalize treatment outcomes. Future research could focus on cost-effective, scalable leukapheresis techniques and broader educational initiatives to heighten awareness in underpenetrated markets. As the market navigates these complexities, strategic positioning in emerging economies, technological enhancements, and compliance with evolving regulatory standards will be crucial for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 56.21 million
Estimated Year [2024] USD 61.62 million
Forecast Year [2030] USD 107.58 million
CAGR (%) 9.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Leukapheresis Market

The Leukapheresis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing application in cancer therapy
    • Demand for leukapheresis in clinical research
    • Growth in initiatives for blood donations
  • Market Restraints
    • High cost of procedure
  • Market Opportunities
    • Focus and investment in R&D activities
    • Leukapheresis for CAR or Adoptive Cell Therapy
  • Market Challenges
    • Potential issues related to leukapheresis including discomfort, redness, and bruising

Porter's Five Forces: A Strategic Tool for Navigating the Leukapheresis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Leukapheresis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Leukapheresis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Leukapheresis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Leukapheresis Market

A detailed market share analysis in the Leukapheresis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Leukapheresis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Leukapheresis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Leukapheresis Market

A strategic analysis of the Leukapheresis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Leukapheresis Market, highlighting leading vendors and their innovative profiles. These include Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa, Guangzhou Daji Medical Science and Technology Co. Ltd., Haemonetics Corporation, Intelligent Tissue Group, Lonza Group Ag, Macopharma Sa, Medica Spa., Miltenyi Biotec, Precision for Medicine, Inc., Puriblood Medical Co. Ltd., Stemexpress, LLC, Terumo BCT, and Zenbio, Inc..

Market Segmentation & Coverage

This research report categorizes the Leukapheresis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Leukapheresis Devices and Leukapheresis Disposables. The Leukapheresis Devices is further studied across Centrifugal Devices and Membrane Separators.
  • Based on Application, market is studied across Research Applications and Therapeutic Applications.
  • Based on End-User, market is studied across Academic & Research Institutes, Blood Component Providers & Blood Centers, Contract Research Organizations, Hospitals & Transfusion Centers, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing application in cancer therapy
      • 5.1.1.2. Demand for leukapheresis in clinical research
      • 5.1.1.3. Growth in initiatives for blood donations
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus and investment in R&D activities
      • 5.1.3.2. Leukapheresis for CAR or Adoptive Cell Therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Potential issues related to leukapheresis including discomfort, redness, and bruising
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing use of leukapheresis devices for efficient separation of white blood cells
    • 5.2.2. Application: Rising application of leukapheresis in therapeutics for improved patient outcome
    • 5.2.3. End-User: Proliferating use of leukapheresis devices by blood component providers & blood centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Leukapheresis Market, by Type

  • 6.1. Introduction
  • 6.2. Leukapheresis Devices
    • 6.2.1. Centrifugal Devices
    • 6.2.2. Membrane Separators
  • 6.3. Leukapheresis Disposables

7. Leukapheresis Market, by Application

  • 7.1. Introduction
  • 7.2. Research Applications
  • 7.3. Therapeutic Applications

8. Leukapheresis Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Blood Component Providers & Blood Centers
  • 8.4. Contract Research Organizations
  • 8.5. Hospitals & Transfusion Centers
  • 8.6. Pharmaceutical & Biotechnology Companies

9. Americas Leukapheresis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Leukapheresis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Leukapheresis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. SCTbio Partners With Cyto-Care To Improve Cell Therapy Cryopreservation
    • 12.3.2. Akadeum Launches T Cell Activation and Expansion Using Positive Selection and Expands Leukopak Cell Isolation Product Lines
    • 12.3.3. Fresenius Kabi Launches Single-Needle Option for the Amicus Extracorporeal Photopheresis Protocol
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allcells, LLC
  • 2. Asahi Kasei Corporation
  • 3. Beijing Zksk Technology Co. Ltd.
  • 4. Bioivt
  • 5. Caltag Medsystems Limited
  • 6. Charles River Laboratories International, Inc.
  • 7. Discovery Life Sciences
  • 8. Fresenius Se & Co. Kgaa
  • 9. Guangzhou Daji Medical Science and Technology Co. Ltd.
  • 10. Haemonetics Corporation
  • 11. Intelligent Tissue Group
  • 12. Lonza Group Ag
  • 13. Macopharma Sa
  • 14. Medica Spa.
  • 15. Miltenyi Biotec
  • 16. Precision for Medicine, Inc.
  • 17. Puriblood Medical Co. Ltd.
  • 18. Stemexpress, LLC
  • 19. Terumo BCT
  • 20. Zenbio, Inc.

LIST OF FIGURES

  • FIGURE 1. LEUKAPHERESIS MARKET RESEARCH PROCESS
  • FIGURE 2. LEUKAPHERESIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LEUKAPHERESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. LEUKAPHERESIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. LEUKAPHERESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LEUKAPHERESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LEUKAPHERESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LEUKAPHERESIS MARKET DYNAMICS
  • TABLE 7. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CENTRIFUGAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LEUKAPHERESIS MARKET SIZE, BY MEMBRANE SEPARATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LEUKAPHERESIS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LEUKAPHERESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LEUKAPHERESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LEUKAPHERESIS MARKET SIZE, BY BLOOD COMPONENT PROVIDERS & BLOOD CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LEUKAPHERESIS MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LEUKAPHERESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. LEUKAPHERESIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. LEUKAPHERESIS MARKET, FPNV POSITIONING MATRIX, 2023